Oscar Health (NYSE:OSCR) Stock Price Crosses Below 200 Day Moving Average – Here’s What Happened

Shares of Oscar Health, Inc. (NYSE:OSCR – Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $24.72 and traded as low as $24.55. Oscar Health shares last traded at $24.68, with a volume of 6,598,842 shares changing hands.

Analyst Ratings Changes

A number of research analysts have recently weighed in on OSCR shares. Piper Sandler dropped their price objective on shares of Oscar Health from $48.00 to $45.00 and set an “overweight” rating for the company in a research note on Friday, November 6th. Bank of America upped their target price on Oscar Health from $28.00 to $30.00 and gave the company an “underperform” rating in a research note on Thursday, September 17th. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $34.00 target price on shares of Oscar Health in a research note on Thursday, September 17th. Barclays increased their target price on Oscar Health from $39.00 to $49.00 and gave the company an “overweight” rating in a report on Thursday, September 17th. Finally, Weiss Ratings downgraded Oscar Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $34.60.

Get Our Latest Stock Report on Oscar Health

Oscar Health Stock Down 5.7%

The stock has a market cap of $7.67 billion, a price-to-earnings ratio of 10.20, a P/E/G ratio of 0.19 and a beta of 2.56. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. The firm’s 50 day moving average is $31.53 and its two-hundred day moving average is $24.72.

Oscar Health (NYSE:OSCR – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.63. The company had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $4.69 billion. Oscar Health had a net margin of 4.90% and a return on equity of 49.39%. The firm’s revenue for the quarter was up 72.1% compared to the same quarter last year. During the same period last year, the company earned ($0.53) EPS. On average, sell-side analysts predict that Oscar Health, Inc. will post 2.48 EPS for the current year.

Insider Activity

In other Oscar Health news, CAO Victoria Baltrus sold 958 shares of the business’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $30,129.10. Following the completion of the transaction, the chief accounting officer directly owned 213,631 shares in the company, valued at approximately $6,718,694.95. The trade was a 0.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Vanessa Wittman sold 25,000 shares of the stock in a transaction on Friday, September 18th. The stock was sold at an average price of $32.24, for a total value of $806,000.00. Following the transaction, the director directly owned 112,121 shares in the company, valued at approximately $3,614,781.04. This represents a 18.23% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 855,701 shares of company stock valued at $26,166,546 in the last 90 days. Insiders own 22.64% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently made changes to their positions in OSCR. Assenagon Asset Management S.A. boosted its stake in Oscar Health by 107.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company’s stock worth $79,867,000 after buying an additional 1,341,716 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Oscar Health by 22.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company’s stock worth $48,078,000 after acquiring an additional 759,837 shares during the period. Halter Ferguson Financial Inc. lifted its holdings in shares of Oscar Health by 93.3% during the 3rd quarter. Halter Ferguson Financial Inc. now owns 1,211,825 shares of the company’s stock worth $37,373,000 after acquiring an additional 584,818 shares during the period. Wedge Capital Management L L P NC purchased a new position in shares of Oscar Health during the 2nd quarter worth about $32,855,000. Finally, Bank of America Corp DE boosted its position in shares of Oscar Health by 205.1% in the first quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after acquiring an additional 1,922,732 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

(Get Free Report)

Oscar Health is a U.S. health insurance company that uses technology and digital tools to connect members with health coverage and care. Founded in 2012, the company initially focused on individual health plans and has expanded its offerings to include coverage for small businesses. Oscar’s products include individual and family plans, generally offered through the Affordable Care Act marketplaces, as well as small-group health insurance. Its services include a mobile app and online tools for managing benefits, finding care, and communicating with care teams.

Further Reading

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.